Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy

被引：28

作者：

Cattan, S

Wendum, D

Chazouilleres, O

Schmitz, J

Gendre, JP

机构：

[1] Hop Rothschild, Serv Hepatogastroenterol, F-75571 Paris 12, France

[2] Hop St Antoine, Serv Anat Pathol, F-75571 Paris, France

[3] Hop St Antoine, Serv Hepatogastroenterol, F-75571 Paris, France

[4] Hop Necker Enfants Malad, Serv Pediat, Paris, France

来源：

HUMAN PATHOLOGY | 2000年 / 31卷 / 07期

关键词：

azathioprine; focal hepatic glycogenosis; hepatocellular carcinoma;

D O I：

10.1053/hupa.2000.7629

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

A 22-year-old woman without predisposing liver disease developed focal hepatic glycogenosis and hepatocellular carcinoma after 6 years of azathioprine therapy for Crohn's disease. Hepatocellular carcinoma without cirrhosis has previously been described during immunosuppression, but this is the first report of disseminated focal hepatic glycogenosis after long-term azathioprine therapy Copyright (C) 2000 by W.B. Saunders Company.

引用

页码：874 / 876

页数：3

共 16 条

[1] AZATHIOPRINE TREATMENT INCREASES HEPATOCYTE TURNOVER [J].